340 related articles for article (PubMed ID: 25616665)
41. SIRT1 promotes the progression and chemoresistance of colorectal cancer through the p53/miR-101/KPNA3 axis.
Wang XW; Jiang YH; Ye W; Shao CF; Xie JJ; Li X
Cancer Biol Ther; 2023 Dec; 24(1):2235770. PubMed ID: 37575080
[TBL] [Abstract][Full Text] [Related]
42. MicroRNA-224 is associated with colorectal cancer progression and response to 5-fluorouracil-based chemotherapy by KRAS-dependent and -independent mechanisms.
Amankwatia EB; Chakravarty P; Carey FA; Weidlich S; Steele RJ; Munro AJ; Wolf CR; Smith G
Br J Cancer; 2015 Apr; 112(9):1480-90. PubMed ID: 25919696
[TBL] [Abstract][Full Text] [Related]
43. Enhanced oxaliplatin-induced apoptosis following antisense Bcl-xl down-regulation is p53 and Bax dependent: Genetic evidence for specificity of the antisense effect.
Hayward RL; Macpherson JS; Cummings J; Monia BP; Smyth JF; Jodrell DI
Mol Cancer Ther; 2004 Feb; 3(2):169-78. PubMed ID: 14985457
[TBL] [Abstract][Full Text] [Related]
44. MiR-22 regulates 5-FU sensitivity by inhibiting autophagy and promoting apoptosis in colorectal cancer cells.
Zhang H; Tang J; Li C; Kong J; Wang J; Wu Y; Xu E; Lai M
Cancer Lett; 2015 Jan; 356(2 Pt B):781-90. PubMed ID: 25449431
[TBL] [Abstract][Full Text] [Related]
45. MicroRNAs as potential therapeutic targets to predict responses to oxaliplatin in colorectal cancer: From basic evidence to therapeutic implication.
Moradi Marjaneh R; Khazaei M; Ferns GA; Avan A; Aghaee-Bakhtiari SH
IUBMB Life; 2019 Oct; 71(10):1428-1441. PubMed ID: 31322820
[TBL] [Abstract][Full Text] [Related]
46. Cepharanthine exhibits a potent anticancer activity in p53-mutated colorectal cancer cells through upregulation of p21Waf1/Cip1.
Rattanawong A; Payon V; Limpanasittikul W; Boonkrai C; Mutirangura A; Wonganan P
Oncol Rep; 2018 Jan; 39(1):227-238. PubMed ID: 29138869
[TBL] [Abstract][Full Text] [Related]
47. The long non-coding RNA HOTAIRM1 suppresses cell progression via sponging endogenous miR-17-5p/ B-cell translocation gene 3 (BTG3) axis in 5-fluorouracil resistant colorectal cancer cells.
Ren T; Hou J; Liu C; Shan F; Xiong X; Qin A; Chen J; Ren W
Biomed Pharmacother; 2019 Sep; 117():109171. PubMed ID: 31261026
[TBL] [Abstract][Full Text] [Related]
48. miR-203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinase.
Zhou Y; Wan G; Spizzo R; Ivan C; Mathur R; Hu X; Ye X; Lu J; Fan F; Xia L; Calin GA; Ellis LM; Lu X
Mol Oncol; 2014 Feb; 8(1):83-92. PubMed ID: 24145123
[TBL] [Abstract][Full Text] [Related]
49. MicroRNA-197 influences 5-fluorouracil resistance via thymidylate synthase in colorectal cancer.
Sun Z; Zhou N; Han Q; Zhao L; Bai C; Chen Y; Zhou J; Zhao RC
Clin Transl Oncol; 2015 Nov; 17(11):876-83. PubMed ID: 26055341
[TBL] [Abstract][Full Text] [Related]
50. Molecular implications of MUC5AC-CD44 axis in colorectal cancer progression and chemoresistance.
Pothuraju R; Rachagani S; Krishn SR; Chaudhary S; Nimmakayala RK; Siddiqui JA; Ganguly K; Lakshmanan I; Cox JL; Mallya K; Kaur S; Batra SK
Mol Cancer; 2020 Feb; 19(1):37. PubMed ID: 32098629
[TBL] [Abstract][Full Text] [Related]
51. Overexpression of MEG3 sensitizes colorectal cancer cells to oxaliplatin through regulation of miR-141/PDCD4 axis.
Wang H; Li H; Zhang L; Yang D
Biomed Pharmacother; 2018 Oct; 106():1607-1615. PubMed ID: 30119236
[TBL] [Abstract][Full Text] [Related]
52. MicroRNA-218 is a prognostic indicator in colorectal cancer and enhances 5-fluorouracil-induced apoptosis by targeting BIRC5.
Li PL; Zhang X; Wang LL; Du LT; Yang YM; Li J; Wang CX
Carcinogenesis; 2015 Dec; 36(12):1484-93. PubMed ID: 26442524
[TBL] [Abstract][Full Text] [Related]
53. MiR-483-3p regulates oxaliplatin resistance by targeting FAM171B in human colorectal cancer cells.
Liang H; Xu Y; Zhang Q; Yang Y; Mou Y; Gao Y; Chen R; Chen C; Dai P
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):725-736. PubMed ID: 30861353
[TBL] [Abstract][Full Text] [Related]
54. Serum miR-19a predicts resistance to FOLFOX chemotherapy in advanced colorectal cancer cases.
Chen Q; Xia HW; Ge XJ; Zhang YC; Tang QL; Bi F
Asian Pac J Cancer Prev; 2013; 14(12):7421-6. PubMed ID: 24460313
[TBL] [Abstract][Full Text] [Related]
55. microRNA-577 suppresses tumor growth and enhances chemosensitivity in colorectal cancer.
Jiang H; Ju H; Zhang L; Lu H; Jie K
J Biochem Mol Toxicol; 2017 Jun; 31(6):. PubMed ID: 28150434
[TBL] [Abstract][Full Text] [Related]
56. MicroRNA-149 Increases the Sensitivity of Colorectal Cancer Cells to 5-Fluorouracil by Targeting Forkhead Box Transcription Factor FOXM1.
Liu X; Xie T; Mao X; Xue L; Chu X; Chen L
Cell Physiol Biochem; 2016; 39(2):617-29. PubMed ID: 27415661
[TBL] [Abstract][Full Text] [Related]
57. microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis.
Zhang C; Liu J; Tan C; Yue X; Zhao Y; Peng J; Wang X; Laddha SV; Chan CS; Zheng S; Hu W; Feng Z
Oncotarget; 2016 Feb; 7(8):8783-96. PubMed ID: 26840028
[TBL] [Abstract][Full Text] [Related]
58. Repression of c-Kit by p53 is mediated by miR-34 and is associated with reduced chemoresistance, migration and stemness.
Siemens H; Jackstadt R; Kaller M; Hermeking H
Oncotarget; 2013 Sep; 4(9):1399-415. PubMed ID: 24009080
[TBL] [Abstract][Full Text] [Related]
59. Reactivating p53 and Inducing Tumor Apoptosis (RITA) Enhances the Response of RITA-Sensitive Colorectal Cancer Cells to Chemotherapeutic Agents 5-Fluorouracil and Oxaliplatin.
Wiegering A; Matthes N; Mühling B; Koospal M; Quenzer A; Peter S; Germer CT; Linnebacher M; Otto C
Neoplasia; 2017 Apr; 19(4):301-309. PubMed ID: 28284059
[TBL] [Abstract][Full Text] [Related]
60. Hypoxia Induces Drug Resistance in Colorectal Cancer through the HIF-1α/miR-338-5p/IL-6 Feedback Loop.
Xu K; Zhan Y; Yuan Z; Qiu Y; Wang H; Fan G; Wang J; Li W; Cao Y; Shen X; Zhang J; Liang X; Yin P
Mol Ther; 2019 Oct; 27(10):1810-1824. PubMed ID: 31208913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]